Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine
Keywords: Alzheimer's disease; Cerebral amyloidosis; Neocortex; Monoamine; Serotonin; Selective serotonin reuptake inhibitor; SERT occupancy; [3H]DASB; Autoradiography; Transgenic mouse model; 5,7-dihydroxytryptamine; Stereology;